Trial Profile
Is premorbid functioning a predictor of outcome in patients with early onset psychosis treated with Risperdal Consta
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2022
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms PROPEL Study
- Sponsors Janssen-Cilag
- 01 Jun 2011 New trial record